🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Limbal Stem Cell Deficiency of Genetic Origin: Genotype-phenotype Correlation

Recruitingn/aAges any - anyAllFondation Ophtalmologique Adolphe de Rothschild
NCT02886611 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study aims at searching for a genotype-phenotype correlation in patients with a genetic pathology of the ocular surface, in order to identify genetic abnormalities associated with the most severe clinical situations.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * genetic pathology of ocular surface Exclusion Criteria: * Agonal glaucoma * Low vision mostly related to retinal pathology * Pregnant or breast feeding patient
💊

What it tests

  • Not listed
📍

Where

1 site
Fondation Ophtalmologique Adolphe de Rothschild
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy